BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 04, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Rifaximin regulatory update

FDA's Gastrointestinal Drugs Advisory Committee will meet on Feb. 23 to discuss an NDA from Salix for rifaximin 550 mg tablets for the maintenance of...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >